Association of interleukin-1 receptor antagonist gene polymorphism and susceptibility to human brucellosis

Tissue Antigens

Volumn 68, Issue 4, 2006, Pages 331-334

  Hajilooi, M ^a   Rafiei, A ^b   Reza Zadeh, M ^c   Tajik, N ^d  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Sina Hospital Hamedan   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brucellosis; Gene polymorphism; Interleukin 1 receptor antagonist

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; BRUCELLOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HETEROZYGOSITY; HUMAN; IMMUNOPATHOGENESIS; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; INTRON; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; BRUCELLOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTRONS; MALE; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES;

EID: 33749557185     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00668.x     Document Type: Article

References (24)

1. Buchanan TM, Hendricks SL, Patton CM, Feldman RA. Brucellosis in the United States, 1960-1972: an abattoir-associated disease. Part III. Epidemiology and evidence for acquired immunity. Medicine (Baltimore) 1974: 53: 427-39.
2. Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM, Soleimani Amiri MJ, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 2004: 132: 1109-14.
3. Refai M. Incidence and control of brucellosis in the Near East region. Vet Microbiol 2002: 90: 81-110.
4. Witkin SS, Linhares I, Giraldo P, Jeremias J, Ledger WJ. Individual immunity and susceptibility to female genital tract infection. Am J Obstet Gynecol 2000: 183: 252-6.
5. Witkin SS, Gerber SS, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002: 34: 204-9.
6. Steinkasserer A, Spurr NK, Cox S, Jeggo P, Sim RB. The human interleukin-1 receptor antagonist (IL1RN) gene maps to chromosome 2q14-q21, in the region of the IL-1α and IL-1β loci. Genomics 1992: 13: 654-7.
7. Dinarello CA. Biology of interleukin 1. FASEB J 1988: 2: 108-15.
8. Arend WP, Malyak M, Guthridge CI, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998: 16: 27-55.
9. McIntyre KW, Stepan GI, Kolinsky KD et al. Inhibition of interleukin-1 binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 1991: 173: 931-9.
10. Tarlow JK, Blakemore AI, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-base pair tandem repeat. Hum Genet 1993: 91: 403-4.
11. Witkin SS, Gerber SS, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002: 34: 204-9.
12. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist gene polymorphism. Clin Exp Immunol 1995: 99: 303-10.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215-8.
14. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000: 404: 398-402.
15. Hu Z, Shao M, Chen Y et al. Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer. Cancer Lett 2006: 236: 269-75.
16. Parkhill JM, Hennig BJ, Chapple IL, Heasman PA, Taylor JJ. Association of interleukin-1 gene polymorphisms with early-onset periodontitis. J Clin Periodontol 2000: 27: 682-9.
17. Chiano MN, Clayton DG. Fine genetic mapping using haplotype analysis and the missing data problem. Ann Hum Genet 1998: 62: 55-60.
18. Bidwell J, Keen L, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999: 1: 3-19.
19. Hacker UT, Gomolka M, Keller E et al. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut 1997: 40: 623-7.
20. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 2000: 92: 1151-8.
21. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002: 34: 204-9.
22. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998: 28: 2598-602.
23. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 1998: 47: 195-8.
24. Vamvakopoulos J, Green C, Metcalfe S. Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 2002: 32: 2988-96.